A recent publication* from Barts Cancer Institute (BCI) highlights how the use of unique molecular identifiers (UMIs) can greatly increase the accuracy of detection of low-quality DNA with much improved allelic quantifications, e.g., for FFPE and ctDNA.
The paper features data generated by a custom hybridisation gene targeting panel from Nonacus1. Testing this panel on FFPE and FF samples from follicular lymphoma biopsies found that a large number (>50-100) consensus sequences in FFPE samples had PCR duplicate reads.
*Applications and analysis of targeted genomic sequencing in cancer studies, Bewicke-Copley et al., Computational and Structural Biotechnology Journal, November 2019.
- Nonacus specializes in high-quality tools for research involving cfDNA samples. Nonacus gene targeting panels for NGS include exome, exome CG and custom gene panels. All Nonacus Cell3™ Target Panels have been designed to ensure confident calling of all mutations down to 0.1% VAF. Nonacus is represented througout The Nordic countries by You Do Bio.
With over 20 years experience in the field of laboratory technology, my job is to help you reach your research goals.
You Do Bio has a diverse portfolio of products, from several companies, backed up by the inventive minds that developed them. Whatever your problem, I will work together with my suppliers to find a solution.
